tirzepatide flu Pharmacist issues urgent warning to those using weight loss jabs as spreads Tirzepatide and Flu Season: Safety

Balancing caffeine intake without compromising health is vital

Psychopharmacology , 98(2), 287289

Clinician review timelines vary, creating pauses that are not tied to errors or missing information

In glycemic control trials in adults with type 2 diabetes mellitus (monotherapy and combination therapy) [see Clinical Studies (14.2, 14.3)], during a treatment period ranging from 24 to 104 weeks, 64/3,907 (1.6%) of TRULICITY-treated patients developed anti-dulaglutide antibodies (referred to as anti-drug-antibodies (ADA))

More than 80% of participants achieved at least 5% weight reduction, a threshold associated with measurable improvements in metabolic health markers